Nature Communications (Aug 2018)

SLC10A7 mutations cause a skeletal dysplasia with amelogenesis imperfecta mediated by GAG biosynthesis defects

  • Johanne Dubail,
  • Céline Huber,
  • Sandrine Chantepie,
  • Stephan Sonntag,
  • Beyhan Tüysüz,
  • Ercan Mihci,
  • Christopher T. Gordon,
  • Elisabeth Steichen-Gersdorf,
  • Jeanne Amiel,
  • Banu Nur,
  • Irene Stolte-Dijkstra,
  • Albertien M. van Eerde,
  • Koen L. van Gassen,
  • Corstiaan C. Breugem,
  • Alexander Stegmann,
  • Caroline Lekszas,
  • Reza Maroofian,
  • Ehsan Ghayoor Karimiani,
  • Arnaud Bruneel,
  • Nathalie Seta,
  • Arnold Munnich,
  • Dulce Papy-Garcia,
  • Muriel De La Dure-Molla,
  • Valérie Cormier-Daire

DOI
https://doi.org/10.1038/s41467-018-05191-8
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 15

Abstract

Read online

The majority of skeletal dysplasia are caused by pathogenic variants in genes required for glycosaminoglycan (GAG) metabolism. Here, Dubail et al. identify genetic variants in the solute carrier family protein SLC10A7 in families with skeletal dysplasia and amelogenesis imperfecta that disrupt GAG synthesis.